NSF Center for Computer-Assisted Synthesis at Notre Dame names Phase II Center for Chemical Innovation
Imagine a world where the power of chemistry is used in concert with machine learning to solve problems in healthcare, materials science, or energy research. Machine learning can accelerate the synthesis of molecules that hold the key to solving these problems by developing new and more efficient ways of making them.
The Center for Computer-Assisted Synthesis (C-CAS)—recently named one of only seven Phase II National Science Foundation Centers for Chemical Innovation (CCI) in the nation, and the first one in Indiana—will change the way chemists solve these problems and many more, both quickly and effectively. To do so, the National Science Foundation awarded C-CAS $20 million over five years.
“C-CAS is building a future where a chemist designs a new molecule and uses AI to work out how to best make that molecule,” noted Sean L. Jones, Assistant Director for the Mathematical and Physical Sciences Directorate at the NSF. “This will allow industries, including pharmaceuticals, biotechnology, fine chemicals, electronics and more to make molecules more sustainably and affordably. This is a grand research challenge with huge societal impact.”
C-CAS helps chemists focus on which molecules should be made, rather than on how to make them. By reducing the time and resources needed to design and optimize synthetic routes, the tools and protocols developed in C-CAS provide data-driven approaches to make synthetic chemistry more predictable and efficient because less time is spent on trial-and-error approaches. The tools developed by C-CAS are then shared with the research community through open-source clearinghouses.
C-CAS will also contribute to making the US a leader in science and technology through attracting, educating and training a new generation of “data chemists” that includes novel opportunities for researchers from underrepresented groups.
C-CAS is a nexus of collaboration, innovation, and education, whose impact is amplified by an extensive network of academic researchers, companies, non-profits, and other research centers. This provides C-CAS with a unique opportunity to help shape the future of synthetic chemistry and the fields that rely on it such as medicine, materials, and energy.
The CCI Program is a highly competitive, two-phase program. Phase I CCIs receive resources to develop the science, management and broader impact components of a major research center dedicated to a transformative idea before requesting Phase II funding.
“With its collaborative network of data scientists, computer scientists and synthetic and computational chemists, C-CAS is poised to introduce potentially paradigm-shifting approaches.” said David Berkowitz, the Director of the NSF Division of Chemistry. “This Center for Chemical Innovation promises to add an important data-driven dimension to synthesis to complement the intuition of the synthetic chemist, while building on the principles of mechanistic understanding, atom economy, symmetry and convergency.”
C-CAS is led by Olaf Wiest, Professor in the Department of Chemistry and Biochemistry at Notre Dame and brings together the expertise of data scientists, computational and synthetic chemists to change the field of synthetic chemistry from an intuition-driven to a data-driven science. Collaborators at Notre Dame include principal investigators Nitesh Chawla, the Frank M. Freimann Professor of Computer Science and Engineering, and Xiangliang Zhang, Associate Professor of Computer Science and Engineering.
"Over the last 15 years, chemists have learned to generate much bigger datasets using computation and high throughput experimentation, but are often not equipped to take full advantage of them,” said Wiest. “C-CAS will develop and share the concepts, datasets and tools to transform the practice of synthesis by maximizing the value of a quantitative approach to data analysis."
External faculty affiliates include Connor Coley at MIT, Abby Doyle and Wei Wang at UCLA, Gabriel Gomes and Olexandr Isayev at Carnegie Mellon University, Hosea Nelson and Sarah Reisman at CalTech, Rob Paton at Colorado State University, Richmond Sarpong and Dean Toste at UC-Berkeley, and Matthew Sigman at the University of Utah.
An important part of C-CAS is the Data Chemists Network, a group of faculty with distinguished expertise ranging from synthetic chemistry to science communication at institutions that typically do not participate in large research centers. The perspectives and skills of Raychelle Burks at American University, Andre Isaacs at College of the Holy Cross, Nicholas Ball at Pomona College, Jessica Kisunzu at Colorado College, and Ampofo Darko at University of Tennessee therefore greatly enhance the reach and capabilities of C-CAS.
C-CAS is funded by NSF through CHE-2202693. For additional information on C-CAS, visit ccas.nd.edu
Originally published by science.nd.edu on August 11, 2022.
atLatest Research
- Engineers seek “switchable” materials to power next-generation microelectronicshris Hinkle is on the hunt for new materials. He needs them to power faster, smaller and more efficient chips for next-generation microelectronics, so only materials with the right chemistry and structure will do. “Current materials are not able to keep up with the growing needs for very tightly packed components,” said Hinkle, Leonard C. Bettex Professor of Electrical Engineering at the University of Notre Dame. “The materials used previously are simply falling short of performance requirements.” Hinkle, who is principal investigator on a new NSF-funded, multi-institutional semiconductor project, is looking for “switchable” semiconductor materials that can either conduct or impede the flow of electricity when activated by an external trigger.
- Cancer therapies show promise in combating tuberculosisA study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery. Published in the Proceedings of the National Academy of Sciences, the study leverages decades of cancer research to study tuberculosis-affected lung tissue and improve treatment.
- Notre Dame as a leading research universityThe University of Notre Dame has experienced transformational growth in research over the past decade. The evidence is everywhere on campus, both in the talent of the faculty and the resources devoted to making Notre Dame a leading research institution. In this episode of Notre Dame Stories,…
- Notre Dame faculty conduct translational research to address tuberculosis in lung cellsFor over 8,000 years, the “white death,” tuberculosis (TB), has plagued humankind. Its effects are described in Biblical verses and appear in mummies from Ancient Egypt. Those infected with Mycobacterium tuberculosis, which causes TB, can now be cured thanks to modern health advancements —…
- Two researchers from the University of Notre Dame receive recognition for publications and images from the Notre Dame Integrated Imaging Facility (NDIIF).Two researchers from the University of Notre Dame are recieving recognition for publications and images from the Notre Dame Integrated Imaging Facility (NDIIF). Each year, the NDIIF provides imaging awards to recognize and honor researchers who use the facility…
- Notre Dame sends cancer research aboard the International Space StationUniversity of Notre Dame researchers will gather new insights about cancerous tumors by taking their science to space aboard NASA’s 30th SpaceX commercial resupply services mission.